MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
STERIS plc Interest Expense 2011-2026 | STE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense STERIS plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.4 M | 11 M | -2.88 M | 89.5 M | 37.2 M | 40.3 M | 45 M | 50.6 M | 44.5 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 89.5 M | -2.88 M | 36 M |
Quarterly Interest Expense STERIS plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.4 M | 1.8 M | - | 2.43 M | 1.1 M | 1.3 M | - | 2.08 M | 1.24 M | 32.4 M | - | 28.6 M | 26.1 M | 22.7 M | - | 23 M | 67.8 M | 44.8 M | - | 8.9 M | 8.9 M | 8.66 M | 9.49 M | 9.81 M | 9.81 M | 10.4 M | 10.4 M | 10.9 M | 11.4 M | 11.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 67.8 M | 1.1 M | 14.7 M |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
408 M | $ 20.22 | -0.74 % | $ 10.3 B | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 72.55 | -1.96 % | $ 3.65 B | USA |
 |
ICU Medical
ICUI
|
107 M | $ 156.76 | 1.06 % | $ 3.82 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.74 | 2.22 % | $ 176 M | USA |
 |
Repro Med Systems
KRMD
|
561 K | $ 5.57 | -1.76 % | $ 254 M | USA |
 |
Alcon
ALC
|
192 M | $ 79.29 | -0.48 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 87.95 | 1.68 % | $ 1.97 B | USA |
 |
AtriCure
ATRC
|
-326 K | $ 39.46 | -4.84 % | $ 1.85 B | USA |
 |
electroCore
ECOR
|
6.3 M | $ 7.17 | 5.65 % | $ 39.5 K | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 141.12 | 0.89 % | $ 7.52 B | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 10.43 | -5.27 % | $ 426 M | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 82.65 | 0.41 % | $ 16.5 B | USA |
 |
Harvard Bioscience
HBIO
|
-227 K | $ 0.59 | 1.28 % | $ 25 M | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 120.04 | 4.86 % | $ 5.81 B | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 8.81 | 2.44 % | $ 182 M | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
OraSure Technologies
OSUR
|
-380 K | $ 2.7 | -1.64 % | $ 201 M | USA |
 |
iRhythm Technologies
IRTC
|
1.25 M | $ 167.42 | -2.69 % | $ 5.22 B | USA |
 |
Predictive Oncology
POAI
|
3 | $ 6.15 | -13.12 % | $ 33.5 M | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 82.27 | 2.39 % | $ 4.79 B | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 2.17 | 4.07 % | $ 22.1 M |  Israel |
 |
Nephros
NEPH
|
2 K | $ 4.35 | -0.8 % | $ 45.2 M | USA |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.29 | -0.82 % | $ 23.1 M | USA |
 |
Utah Medical Products
UTMD
|
256 K | $ 61.25 | 1.63 % | $ 222 M | USA |
 |
Envista Holdings Corporation
NVST
|
-100 K | $ 25.27 | 2.35 % | $ 4.35 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 42.3 | 1.37 % | $ 139 M | USA |
 |
Pulse Biosciences
PLSE
|
983 K | $ 14.29 | 1.31 % | $ 686 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 207.62 | -0.35 % | $ 59.7 B | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 163.82 | 1.31 % | $ 9.13 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 257.35 | -1.29 % | $ 37.6 B | USA |
 |
BioLife Solutions
BLFS
|
497 K | $ 24.35 | -0.49 % | $ 1.12 B | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.72 | -2.34 % | $ 220 M | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.74 | 3.27 % | $ 22.2 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 20.89 | -0.38 % | $ 1.03 B | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 103.32 | -1.23 % | $ 4.84 B | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 260.85 | -6.64 % | $ 19 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.23 | -2.78 % | $ 2.49 B | USA |